site | 
site
News Release
Fertell: The First At-Home Fertility Screening for
Both Men and Women Now Available in the US
Revolutionary easy-to-use test helps couples accelerate the path towards conception
NEEDHAM, MA (June 4, 2007) – Fertility issues affect one in seven couples in the United States and more than six million women and their partners report difficulties conceiving, according to the Centers for Disease Control. Today Genosis, Inc., announced the introduction of Fertell, the first at-home fertility screening test for men and women offering new help for couples on the journey towards conception. Fertell enables couples to accurately assess key elements of both male and female fertility in the comfort and privacy of their home making it easier for both partners, particularly the male, to participate earlier in evaluating fertility. Fertell has been cleared by the FDA and can be purchased over-the-counter at CVS/pharmacy and Longs Drugs Stores as well as online at www.Fertell.com.
The only test of its kind, Fertell uses innovative screening technology to give couples valuable insight into the fertility of both partners before physician-based testing is appropriate. The kit includes both male and female tests that are clinically proven 95 percent accurate compared to standard laboratory tests. Early detection of fertility issues can significantly increase a couple's chances of conceiving, according to the American Society for Reproductive Medicine (ASRM).
"Fertell is a tremendous advance and an important first step for couples who have questions about their fertility," said Samantha Pfeifer, M.D., associate professor of obstetrics and gynecology at the University of Pennsylvania. "By offering couples lab quality tests they can take at home, Fertell can identify couples who may in fact have fertility issues and get them to doctors' offices earlier in the process. It can also help ease the concerns of others who are trying to conceive."
The conception process can be a stressful time for couples who do not conceive as quickly as they hoped. Now, Fertell allows couples to take the first step to screening fertility in the privacy of their home. Many men are reluctant to provide a doctor or nurse with the semen sample necessary for fertility screening, often delaying the process. Fertell helps to eliminate this discomfort, easing the male into the process sooner and educating him on his critical role in fertility evaluation.
"We are excited to be introducing this breakthrough in fertility screening to couples in the U.S.," said Robert Thompson, President of Genosis. "Many women believe that the ability to conceive a baby is primarily up to them. In fact, research shows that issues affecting fertility are almost evenly split between the sexes. Because of this, it is essential to involve and screen both partners."
How Fertell Works:
The male fertility test measures the concentration of motile sperm—a key indicator of sperm health – using an innovative process to simulate sperm swimming through cervical fluid to reach the egg. Results for the male test can be read in 80 minutes. The female fertility test measures Follicle Stimulating Hormone (FSH) levels in a woman’s urine on the third day of her menstrual cycle. FSH is a key indicator of Ovarian Reserve, which is a measure of the age of a woman's ovaries and their ability to respond to FSH in order to produce eggs that can be fertilized. The female fertility test is conducted much like an at-home pregnancy test and results can be read in 30 minutes.
Leading patient advocacy groups have also recognized the benefits of Fertell. "For some couples, Fertell can make all the difference," says Pamela Madsen, Executive Director and Founder of the American Fertility Association. "I believe knowledge is power. Now, for the first time, with Fertell a couple has the ability to find out about some important aspects of each partner's fertility," she explained.
While Fertell is now making its debut in the United States, it has been available in the United Kingdom and Ireland for over a year, and has helped thousands of couples get vital information about key fertility indicators.
Fertell is committed to caring for its customers, and offers a toll-free Careline number staffed by nurses and trained professionals 24 hours a day.
The Fertell kit, containing both male and female fertility tests, has a suggested retail price under $100.
For more information about fertility, conception planning and Fertell fertility tests, or to purchase the screening kit, men and women can visit www.Fertell.com.
About Genosis:
Genosis Inc., based in Needham, Massachusetts, distributes Fertell, the first at-home fertility screening test for couples. Fertell’s patented, clinically-proven technology combines electronics and biomedical components to provide an accurate, evaluation of fertility status for couples who want to accelerate the path towards conception. Fertell is FDA cleared and tests key elements of both male and female fertility. These fertility tests can be taken in the comfort of a couple's home, with results in under 90 minutes. For more information about fertility, conception planning and Fertell, visit www.Fertell.com.
